Cambrian BioPharma Inc is 10% Owner at Sensei Biotherapeutics, Inc. (SNSE). They have made 40 open-market trades across 1 company since 2021, most recently 2026-06-01.
CIK 0001797409
37 open-market purchases totalling $2.4M since 2021, against 3 sales. Across 37 scored buys the stock is down 43.8% at ninety days, and 44.0 points behind the S&P over the same stretch.
37 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| SNSE | 130,142 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-06-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 16% | 3% | 3% |
| Avg Move | -7.5% | -20.0% | -43.8% |
| Alpha | -7.2% | -20.2% | -44.0% |
| Scored | 37 | 37 | 37 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNSE | SELL | 2026-06-01 | 2026-06-01 | $20.02 | $501K | -43.8% | N/A | N/A |
| SNSE | SELL | 2025-12-09 | 2025-12-10 | $8.25 | $55K | +18.2% | +44.1% | +272.2% |
| SNSE | SELL | 2025-12-04 | 2025-12-08 | $10.93 | $233K | +9.5% | +34.7% | +254.1% |
| SNSE | BUY | 2022-03-02 | 2022-03-02 | $3.20 | $4K | -20.2% | -32.0% | -42.6% |
| SNSE | BUY | 2022-02-28 | 2022-03-01 | $3.60 | $9K | -23.9% | -34.9% | -46.5% |
| SNSE | BUY | 2022-02-25 | 2022-02-28 | $3.65 | $9K | -17.0% | -36.2% | -47.9% |
| SNSE | BUY | 2022-02-23 | 2022-02-24 | $3.80 | $10K | -17.2% | -40.1% | -56.2% |
| SNSE | BUY | 2022-02-17 | 2022-02-22 | $4.17 | $21K | -19.3% | -34.3% | -57.5% |
| SNSE | BUY | 2022-02-14 | 2022-02-16 | $4.19 | $53K | -16.4% | -33.4% | -59.7% |
| SNSE | BUY | 2022-02-10 | 2022-02-14 | $4.45 | $78K | -9.4% | -37.3% | -61.4% |
| SNSE | BUY | 2022-02-04 | 2022-02-08 | $4.35 | $54K | -6.8% | -31.3% | -65.3% |
| SNSE | BUY | 2022-01-27 | 2022-01-31 | $4.26 | $64K | -3.4% | -28.1% | -65.5% |
| SNSE | BUY | 2022-01-21 | 2022-01-25 | $4.82 | $229K | -6.0% | -24.3% | -62.3% |
| SNSE | BUY | 2022-01-19 | 2022-01-21 | $4.97 | $51K | +2.5% | -19.8% | -61.7% |
| SNSE | BUY | 2022-01-13 | 2022-01-18 | $5.10 | $133K | -12.5% | -20.7% | -63.1% |
| SNSE | BUY | 2022-01-11 | 2022-01-13 | $5.20 | $104K | -13.3% | -18.9% | -59.2% |
| SNSE | BUY | 2021-12-29 | 2021-12-30 | $4.98 | $344K | -2.0% | -12.4% | -57.6% |
| SNSE | BUY | 2021-12-28 | 2021-12-29 | $5.28 | $60K | +8.9% | -6.6% | -54.2% |
| SNSE | BUY | 2021-12-27 | 2021-12-27 | $5.30 | $20K | +2.8% | -19.4% | -58.7% |
| SNSE | BUY | 2021-12-23 | 2021-12-23 | $5.27 | $58K | -1.4% | -12.8% | -56.8% |
| SNSE | BUY | 2021-12-17 | 2021-12-21 | $5.29 | $619 | +7.2% | -9.7% | -55.1% |
| SNSE | BUY | 2021-12-16 | 2021-12-20 | $5.25 | $57K | -3.2% | -17.0% | -57.6% |
| SNSE | BUY | 2021-05-05 | 2021-05-06 | $12.00 | $4K | -18.6% | +6.4% | -35.2% |
| SNSE | BUY | 2021-04-20 | 2021-04-21 | $12.77 | $5K | -5.6% | -6.9% | -48.7% |
| SNSE | BUY | 2021-04-19 | 2021-04-20 | $13.38 | $26K | +1.4% | -3.1% | -46.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.